Research and Markets: Global Influenza Vaccine Market Outlook 2020

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/kstzkn/global_influenza) has announced the addition of the "Global Influenza Vaccine Market Outlook 2020" report to their offering.

The global volume sales of influenza vaccine is expected to grow at a CAGR of 5.5% during the forecasted period, 2014-2020

Influenza vaccines are considered as an optimum source of prevention from diseases caused by flu virus. Since the H1N1 pandemic, worldwide authorities have started to adopt proactive approach in the vaccination process. Virus of previous pandemics are still circulating in the environment and in the coming future, they may be classified as strains to be updated in seasonal vaccines. Moreover, a large chunk of global population is affected by influenza-related problems. In such a scenario, huge opportunity lies for industry participants to tap the fast growing market.

In 2014, the global market for influenza vaccines has shown tremendous growth backed by certain key prominent factors. Approval of new seasonal influenza vaccines by authorities and significant developments in adjuvant technology are going to impact the market in a positive manner.

Emerging markets predominantly is the main focus in the global influenza vaccine market landscape. Vast population base together with significantly low vaccination coverage are the prominent factors that will drive the future growth in countries, such as China and India. Market players have already started devising strategies including agreements with domestic manufacturers/distributors to increase their presence in China. India, on the contrary, is engaged in the collection of data that may facilitate in the development of flu vaccination strategies among the population.

Key Topics Covered:

1. Analyst View

2. Research Methodology

3. Influenza Vaccine - Introduction

4. Global Influenza Vaccine Market Outlook 2020

5. Key Geographical Market

6. Global Influenza Vaccine Market: Pipeline Analysis

7. Global Influenza Vaccine Market: Pricing Analysis

8. Competitive Assessment

  • Sanofi
  • GlaxoSmithKline Plc (GSK)
  • CSL Ltd
  • AstraZeneca Plc
  • Sinovac Biotech
  • Serum Institute of India

For more information visit http://www.researchandmarkets.com/research/kstzkn/global_influenza

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals